About: covid:PMC7169085

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7169085 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Memish, Ziad Ahmed, Sarah Hirayama, Kenji Huy, Nguyen Omrani, Ali Kamel, Mohamed Morra, Mostafa Altibi, Ahmed Dat, Lu Elabd, Sahar Fathima, Samreen Ghazy, Ahmed Le Huy Vu, Tran Mostafa, Mostafa Thy, Tran Van Thanh, Le Vuong, Nguyen
is schema:about of	named entity 'CLINICAL OUTCOMES' named entity 'flu-like symptoms' named entity 'renal replacement therapy' named entity 'IFN' named entity 'infection' named entity 'MERS' named entity 'antiviral treatment' named entity 'CART' named entity 'PPV' named entity 'beta-1a' named entity 'chronic kidney disease' named entity 'supportive treatment' named entity 'renal replacement therapy' named entity 'clinical features' named entity 'corticosteroid' named entity 'infection' named entity 'disinfecting' named entity 'SIGLE' named entity 'hypertension' named entity '5 references' named entity 'survival analysis' named entity 'lopinavir' named entity 'supportive treatment' named entity 'NPV' named entity 'chronic respiratory disease' named entity 'IFN' named entity 'oxygen therapy' named entity 'Saudi Arabia' named entity 'respiratory symptoms' named entity 'IFN' named entity 'supportive care' named entity 'MERS-CoV' named entity 'survival time' named entity 'intubated' named entity 'dialysis' named entity 'antiviral' named entity 'NPV' named entity 'mechanical ventilation' named entity '95% CI' named entity 'emtricitabine' named entity '95% CI' named entity '4.07' named entity 'ribavirin' named entity 'combination therapy' named entity 'MERS' named entity 'prone position' named entity 'MERS-CoV' named entity 'chronic renal disease' named entity 'significant difference' named entity 'oseltamivir' named entity 'Google Scholar' named entity 'hemoglobin' named entity 'STATA' named entity 'ribavirin' named entity 'SpO2' named entity 'systematic reviews' named entity 'POPLINE' named entity 'adverse effects' named entity 'MERS' named entity '21 days' named entity 'asymptomatic' named entity 'meta-analysis' named entity 'IFN' named entity 'meta-analysis' named entity '21.3' named entity 'health care professionals' named entity 'MERS' named entity 'tenofovir' named entity 'cough' named entity 'hypertension' named entity 'data extraction' named entity 'immunoglobulins' named entity 'ribavirin' named entity 'mechanical ventilation' named entity 'IFN' named entity 'MERS' named entity 'beta-1a' named entity 'statistical significance' named entity 'significant difference' named entity 'diagnostic methods' named entity 'NPV' named entity 'antiviral treatment' named entity 'MERS'

Attributes

Values

Creator

Memish, Ziad
Ahmed, Sarah
Hirayama, Kenji
Huy, Nguyen
Omrani, Ali
Kamel, Mohamed
Morra, Mostafa
Altibi, Ahmed
Dat, Lu
Elabd, Sahar
Fathima, Samreen
Ghazy, Ahmed
Le Huy Vu, Tran
Mostafa, Mostafa
Thy, Tran
Van Thanh, Le
Vuong, Nguyen

is schema:about of

named entity 'CLINICAL OUTCOMES'
named entity 'flu-like symptoms'
named entity 'renal replacement therapy'
named entity 'IFN'
named entity 'infection'
named entity 'MERS'
named entity 'antiviral treatment'
named entity 'CART'
named entity 'PPV'
named entity 'beta-1a'
named entity 'chronic kidney disease'
named entity 'supportive treatment'
named entity 'renal replacement therapy'
named entity 'clinical features'
named entity 'corticosteroid'
named entity 'infection'
named entity 'disinfecting'
named entity 'SIGLE'
named entity 'hypertension'
named entity '5 references'
named entity 'survival analysis'
named entity 'lopinavir'
named entity 'supportive treatment'
named entity 'NPV'
named entity 'chronic respiratory disease'
named entity 'IFN'
named entity 'oxygen therapy'
named entity 'Saudi Arabia'
named entity 'respiratory symptoms'
named entity 'IFN'
named entity 'supportive care'
named entity 'MERS-CoV'
named entity 'survival time'
named entity 'intubated'
named entity 'dialysis'
named entity 'antiviral'
named entity 'NPV'
named entity 'mechanical ventilation'
named entity '95% CI'
named entity 'emtricitabine'
named entity '95% CI'
named entity '4.07'
named entity 'ribavirin'
named entity 'combination therapy'
named entity 'MERS'
named entity 'prone position'
named entity 'MERS-CoV'
named entity 'chronic renal disease'
named entity 'significant difference'
named entity 'oseltamivir'
named entity 'Google Scholar'
named entity 'hemoglobin'
named entity 'STATA'
named entity 'ribavirin'
named entity 'SpO2'
named entity 'systematic reviews'
named entity 'POPLINE'
named entity 'adverse effects'
named entity 'MERS'
named entity '21 days'
named entity 'asymptomatic'
named entity 'meta-analysis'
named entity 'IFN'
named entity 'meta-analysis'
named entity '21.3'
named entity 'health care professionals'
named entity 'MERS'
named entity 'tenofovir'
named entity 'cough'
named entity 'hypertension'
named entity 'data extraction'
named entity 'immunoglobulins'
named entity 'ribavirin'
named entity 'mechanical ventilation'
named entity 'IFN'
named entity 'MERS'
named entity 'beta-1a'
named entity 'statistical significance'
named entity 'significant difference'
named entity 'diagnostic methods'
named entity 'NPV'
named entity 'antiviral treatment'
named entity 'MERS'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software